Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Toxicology Drug Screening Market Size, Value And Growth Trends Through 2030
The toxicology drug screening market has experienced significant expansion over the past several years, with its valuation climbing from $21.44 billion in 2025 to an anticipated $23.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.6%. This upward trajectory during the historical period was largely driven by factors such as a dependence on manual toxicology testing techniques, minimal levels of laboratory automation, a rising frequency of substance abuse monitoring programs, heightened regulatory scrutiny, and the integration of traditional bioanalytical instruments.
The toxicology drug screening market is projected to experience robust expansion over the coming years, reaching a valuation of $33.48 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by factors such as the emergence of AI-powered predictive toxicology tools, the incorporation of genomics and transcriptomics into screening processes, the proliferation of contract research organizations (CROs), an increasing need for real-time drug monitoring systems, and the deployment of cloud-based and secure data management platforms. Key trends influencing this period encompass a rising reliance on high-throughput screening technologies, the integration of laboratory information management systems (LIMS), the growing utilization of predictive and AI-enhanced toxicology platforms, the broadening of workplace drug screening initiatives, and a heightened emphasis on data security and regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
Toxicology Drug Screening Market Growth Drivers And Industry Catalysts
The growing incidence of substance abuse is anticipated to drive the expansion of the toxicology drug screening market in the coming years. Drug abuse refers to the harmful or excessive consumption of drugs for non-therapeutic purposes, which adversely affects an individual’s health and overall well-being. This trend is escalating due to heightened stress levels and mental health issues, prompting many people to turn to substance misuse as a coping mechanism. Toxicology drug screening plays a crucial role in addressing drug abuse by identifying the presence of drugs or their metabolites in the body, facilitating early detection, diagnosis, and monitoring of substance misuse or overdose. For example, in August 2024, the National Records of Scotland (NRS), a government agency based in Scotland, reported 1,172 drug misuse deaths in 2023, representing a 12% increase (121 more deaths) compared to 2022. Consequently, the rising prevalence of drug abuse is fueling growth in the toxicology drug screening market.
Toxicology Drug Screening Market Segment Analysis: What Are The Major Market Categories?
The toxicology drug screening market covered in this report is segmented –
1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems
2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity
3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening
4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications
5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities
Subsegments:
1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays
2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests
3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits
4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits
5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips
6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems
Toxicology Drug Screening Market Trends Influencing Long-Term Demand
Key players in the toxicology drug screening industry are concentrating on launching innovative products, such as the 3D liver microphysiological system, a technology that enables the cultivation of highly biomimetic human liver microtissues characterized by organized cellular structures and robust metabolic activity. This 3D liver microphysiological system (MPS) represents a sophisticated in vitro platform, engineered to more faithfully mimic the human liver’s physiological surroundings compared to conventional cell culture methods, typically involving the culture of diverse human liver cell types. A concrete example occurred in February 2025 when CN Bio Innovations Ltd., a UK-based life sciences firm specializing in organ-on-a-chip (OOC) technologies, introduced the PhysioMimix DILI assay kit. This integrated laboratory kit was designed for in vitro evaluation of human drug-induced liver injury, incorporating a well-characterized 3D liver MPS that reconstructs metabolically active, highly functional human liver tissue along with Kupffer cells. Moreover, it facilitates seamless integration of organ-on-a-chip technology through a plug-and-play format, streamlining implementation and shortening the time required for widespread adoption.
Toxicology Drug Screening Market Leading Companies Driving Competitive Growth
Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.
Access The Complete Toxicology Drug Screening Market Report:
Toxicology Drug Screening Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model